US2022056529A1PendingUtilityA1
Identification of pediatric onset inflammatory bowel disease loci and methods for use thereof for the diagnosis and treatment of the same
Assignee: CHILDRENS HOSPITAL PHILADELPHIAPriority: Feb 19, 2008Filed: Sep 3, 2021Published: Feb 24, 2022
Est. expiryFeb 19, 2028(~1.6 yrs left)· nominal 20-yr term from priority
C12Q 2600/172C12Q 1/6883C12Q 2600/158C12Q 2600/136C12Q 2600/156
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compositions and methods for the detection and treatment of inflammatory bowel disease are provided.
Claims
exact text as granted — not AI-modified1 .- 12 . (canceled)
13 . A solid support comprising a nucleic acid comprising at least one inflammatory bowel disease (IBD)-associated single nucleotide polymorphism (SNP) selected from a Tat rs2315008 in the TNFRSF6B gene, an A at rs4809330 in the TNFRSF6B gene, and an A at rs2836878 in the PSMG1 gene.
14 .- 20 . (canceled)
21 . The solid support of claim 13 , further comprising at least one additional IDB-associated SNP selected from the IBD-associated SNPs listed in Table 6A, Table 6B, Table 13, Table 14, Table 15, Table 16, Table 17, Table 18, and Table 19.
22 . The solid support of claim 13 , wherein said IBD-associated SNP is associated with at least one of Chron's Disease (CD) and Ulcerative Colitis (UC).
23 . The solid support of claim 13 , wherein said solid support includes microparticles, a microarray, the surface of a microtitration well or test tube, a biacore chip, a dipstick or a filter.
24 . The solid support of claim 13 , wherein said solid support includes a microarray.
25 . The solid support of claim 13 , wherein the solid support is made of polystryrene, cellulose, latex, nitrocellulose, nylon, polyacrylamide, dextran or agarose.Join the waitlist — get patent alerts
Track US2022056529A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.